Table 1 WHO 2030 targets, sub-targets and milestones for EPHP, achieved when the heavy-intensity prevalence in SAC reduces to less than 1% [8]
From: Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
Indicator | 2023 | 2025 | 2030 |
|---|---|---|---|
Number of countries validated for EPHP | 49/78 (63) | 69/78 (88%) | 78/78 (100%) |
Number of countries where absence of infection in humans has been achieved | 10/78 (13%) | 19/78 (24%) | 25/78 (32%) |